View in EDS

Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab.

Saved in:
Bibliographic Details
Title: Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab.
Authors: Mori K; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan. morikeiichiro29@gmail.com., Yanagisawa T; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan., Kawada T; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Katayama S; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Maenosono R; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Hashimoto T; Department of Urology, Tokyo Medical University, Tokyo, Japan., Hirasawa Y; Department of Urology, Tokyo Medical University, Tokyo, Japan., Inoki L; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan., Toyoda S; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan., Nukaya T; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan., Takahara K; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan., Fukuokaya W; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan., Iwata T; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Bekku K; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Ohno Y; Department of Urology, Tokyo Medical University, Tokyo, Japan., Shiroki R; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan., Fujita K; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan., Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Araki M; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan.
Source: International journal of clinical oncology [Int J Clin Oncol] 2025 Nov; Vol. 30 (11), pp. 2335-2341. Date of Electronic Publication: 2025 Sep 05.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40911129
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mori+K%22">Mori K</searchLink>; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan. morikeiichiro29@gmail.com.<br /><searchLink fieldCode="AU" term="%22Yanagisawa+T%22">Yanagisawa T</searchLink>; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan.<br /><searchLink fieldCode="AU" term="%22Kawada+T%22">Kawada T</searchLink>; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Katayama+S%22">Katayama S</searchLink>; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Maenosono+R%22">Maenosono R</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tsujino+T%22">Tsujino T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hashimoto+T%22">Hashimoto T</searchLink>; Department of Urology, Tokyo Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hirasawa+Y%22">Hirasawa Y</searchLink>; Department of Urology, Tokyo Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Inoki+L%22">Inoki L</searchLink>; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Toyoda+S%22">Toyoda S</searchLink>; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nukaya+T%22">Nukaya T</searchLink>; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Takahara+K%22">Takahara K</searchLink>; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuokaya+W%22">Fukuokaya W</searchLink>; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan.<br /><searchLink fieldCode="AU" term="%22Urabe+F%22">Urabe F</searchLink>; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan.<br /><searchLink fieldCode="AU" term="%22Iwata+T%22">Iwata T</searchLink>; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Bekku+K%22">Bekku K</searchLink>; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Ohno+Y%22">Ohno Y</searchLink>; Department of Urology, Tokyo Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shiroki+R%22">Shiroki R</searchLink>; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Fujita+K%22">Fujita K</searchLink>; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Azuma+H%22">Azuma H</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Araki+M%22">Araki M</searchLink>; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+T%22">Kimura T</searchLink>; Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229616295%22">International journal of clinical oncology</searchLink> [Int J Clin Oncol] 2025 Nov; Vol. 30 (11), pp. 2335-2341. <i>Date of Electronic Publication: </i>2025 Sep 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Tokyo%22">Springer-Verlag Tokyo </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9616295 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1437-7772 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213419625%22">13419625 </searchLink><i>NLM ISO Abbreviation: </i>Int J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40911129
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10147-025-02878-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2335
    Titles:
      – TitleFull: Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mori K
      – PersonEntity:
          Name:
            NameFull: Yanagisawa T
      – PersonEntity:
          Name:
            NameFull: Kawada T
      – PersonEntity:
          Name:
            NameFull: Katayama S
      – PersonEntity:
          Name:
            NameFull: Maenosono R
      – PersonEntity:
          Name:
            NameFull: Tsujino T
      – PersonEntity:
          Name:
            NameFull: Hashimoto T
      – PersonEntity:
          Name:
            NameFull: Hirasawa Y
      – PersonEntity:
          Name:
            NameFull: Inoki L
      – PersonEntity:
          Name:
            NameFull: Toyoda S
      – PersonEntity:
          Name:
            NameFull: Nukaya T
      – PersonEntity:
          Name:
            NameFull: Takahara K
      – PersonEntity:
          Name:
            NameFull: Fukuokaya W
      – PersonEntity:
          Name:
            NameFull: Urabe F
      – PersonEntity:
          Name:
            NameFull: Iwata T
      – PersonEntity:
          Name:
            NameFull: Bekku K
      – PersonEntity:
          Name:
            NameFull: Ohno Y
      – PersonEntity:
          Name:
            NameFull: Shiroki R
      – PersonEntity:
          Name:
            NameFull: Fujita K
      – PersonEntity:
          Name:
            NameFull: Azuma H
      – PersonEntity:
          Name:
            NameFull: Araki M
      – PersonEntity:
          Name:
            NameFull: Kimura T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1437-7772
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: International journal of clinical oncology
              Type: main
ResultId 1